These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33452491)

  • 41. Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities.
    Deiana G; Azara A; Dettori M; Delogu F; Vargiu G; Gessa I; Arghittu A; Tidore M; Steri G; Castiglia P
    BMC Public Health; 2021 Jan; 21(1):83. PubMed ID: 33413218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
    Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
    S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID 19 could trigger global diabetes burden - A hypothesis.
    Mukherjee S; Banerjee O; Singh S; Maji BK
    Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
    [No Abstract]   [Full Text] [Related]  

  • 44. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 45. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Angelidi AM; Belanger MJ; Mantzoros CS
    Metabolism; 2020 Jun; 107():154245. PubMed ID: 32320742
    [No Abstract]   [Full Text] [Related]  

  • 46. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 48. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
    Markus B; Kreutz J; Schieffer B
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320963929. PubMed ID: 33040679
    [No Abstract]   [Full Text] [Related]  

  • 50. Preexisting prediabetes and the severity of COVID-19.
    Sathish T; Cao Y; Kapoor N
    Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435
    [No Abstract]   [Full Text] [Related]  

  • 51. Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
    Pantea Stoian A; Pricop-Jeckstadt M; Pana A; Ileanu BV; Schitea R; Geanta M; Catrinoiu D; Suceveanu AI; Serafinceanu C; Pituru S; Poiana C; Timar B; Nitipir C; Parvu S; Arsene A; Mazilu L; Toma A; Hainarosie R; Ceriello A; Rizzo M; Jinga V
    Sci Rep; 2020 Dec; 10(1):21613. PubMed ID: 33303885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetes and covid-19: a global health challenge.
    Shenoy A; Ismaily M; Bajaj M
    BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32345580
    [No Abstract]   [Full Text] [Related]  

  • 53. [Vulnerability and health risks of people with diabetes to COVID-19].
    Santillán-García A
    Gac Sanit; 2021; 35(6):600-601. PubMed ID: 33551210
    [No Abstract]   [Full Text] [Related]  

  • 54. COVID-19, diabetes mellitus and ACE2: The conundrum.
    Pal R; Bhansali A
    Diabetes Res Clin Pract; 2020 Apr; 162():108132. PubMed ID: 32234504
    [No Abstract]   [Full Text] [Related]  

  • 55. Nexus of COVID-19 and diabetes pandemics: Global public health lessons.
    Bergman M; Jagannathan R; Narayan KMV
    Diabetes Res Clin Pract; 2020 Jun; 164():108215. PubMed ID: 32416122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microvascular disease in diabetes and severe COVID-19 outcomes.
    Corcillo A; Whyte MB; Vas P; Karalliedde J
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):200-201. PubMed ID: 33740436
    [No Abstract]   [Full Text] [Related]  

  • 57. Telemedicine During the COVID-19 Crisis and Beyond.
    Blevins T; Ozer K
    Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Editor's Comment. Caution: The Intersection of Diabetes and COVID-19.
    Chernoff A
    Endocr Res; 2021; 46(2):55-56. PubMed ID: 33730984
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 and diabetes in Africa: a lethal combination.
    Burki T
    Lancet Diabetes Endocrinol; 2022 Jan; 10(1):23. PubMed ID: 34856175
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?
    Tadic M; Cuspidi C
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):235-237. PubMed ID: 33369012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.